Harte Behavioral Health, Llc | |
95 Washington St Ste 588 Canton MA 02021-4003 | |
(781) 713-4001 | |
(781) 713-4038 |
Full Name | Harte Behavioral Health, Llc |
---|---|
Speciality | Psychologist |
Location | 95 Washington St Ste 588, Canton, Massachusetts |
Authorized Official Name and Position | Christopher B Harte (PSYCHOLOGIST/OWNER) |
Authorized Official Contact | 5125673821 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Harte Behavioral Health, Llc 95 Washington St Ste 588 Canton MA 02021-4003 Ph: (781) 713-4001 | Harte Behavioral Health, Llc 95 Washington St Ste 588 Canton MA 02021-4003 Ph: (781) 713-4001 |
NPI Number | 1174916688 |
---|---|
Provider Enumeration Date | 03/07/2015 |
Last Update Date | 03/07/2015 |
Medicare PECOS PAC ID | 9335450311 |
---|---|
Medicare Enrollment ID | O20150617001095 |
News Archive
Howard Hughes Medical Institute scientists at The Salk Institute have discovered a new class of optical illusion that they have studied in detail to show that humans use both the timing and spatial context of a visual stimulus to judge brightness.
The second episode in a three-part series on Grey's Anatomy features a patient with von Hippel-Lindau disease (VHL). The next new episode in the show is expected to air on January 6. The first episode, "Adrift and at Peace," aired Dec. 2.
Virginia Tech Intellectual Properties (VTIP) announces that the US Patent and Trademark Office has granted a patent for targets and methods to develop new drugs for malaria.
Responding to reports in the media that Obecalp, a placebo pill for children, is due to be made available on the UK market, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Chief Scientist, Jayne Lawrence said:
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1174916688 | NPI | - | NPPES |
S400192644 | Other | MA | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 9809 (Massachusetts) | Primary |
Provider Name | Christopher Brookes Harte |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1588090823 PECOS PAC ID: 2860717683 Enrollment ID: I20150218001923 |
News Archive
Howard Hughes Medical Institute scientists at The Salk Institute have discovered a new class of optical illusion that they have studied in detail to show that humans use both the timing and spatial context of a visual stimulus to judge brightness.
The second episode in a three-part series on Grey's Anatomy features a patient with von Hippel-Lindau disease (VHL). The next new episode in the show is expected to air on January 6. The first episode, "Adrift and at Peace," aired Dec. 2.
Virginia Tech Intellectual Properties (VTIP) announces that the US Patent and Trademark Office has granted a patent for targets and methods to develop new drugs for malaria.
Responding to reports in the media that Obecalp, a placebo pill for children, is due to be made available on the UK market, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Chief Scientist, Jayne Lawrence said:
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
› Verified 6 days ago
News Archive
Howard Hughes Medical Institute scientists at The Salk Institute have discovered a new class of optical illusion that they have studied in detail to show that humans use both the timing and spatial context of a visual stimulus to judge brightness.
The second episode in a three-part series on Grey's Anatomy features a patient with von Hippel-Lindau disease (VHL). The next new episode in the show is expected to air on January 6. The first episode, "Adrift and at Peace," aired Dec. 2.
Virginia Tech Intellectual Properties (VTIP) announces that the US Patent and Trademark Office has granted a patent for targets and methods to develop new drugs for malaria.
Responding to reports in the media that Obecalp, a placebo pill for children, is due to be made available on the UK market, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Chief Scientist, Jayne Lawrence said:
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.
› Verified 6 days ago
Integrated Center For Child Development Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 340 Turnpike St, Suite 11a, Canton, MA 02021 Phone: 617-641-0900 Fax: 617-641-0930 | |
Sharon Behavioral Health, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 95 Washington St Ste 234, Canton, MA 02021 Phone: 617-589-1996 | |
Always Upward, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 25 Woodcliff Rd, Canton, MA 02021 Phone: 774-526-4719 | |
Help For Adult Life Experience Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5 Stratford Rd, Canton, MA 02021 Phone: 401-216-7572 | |
The Commonwealth Center For Psychotherapy Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 345 Neponset Street, Canton, MA 02021 Phone: 781-828-1222 Fax: 781-828-5454 | |
Waves Counseling Group Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 28 Oakdale Rd, Canton, MA 02021 Phone: 508-686-6494 |